ChiCTR2600126208 版本V1.0 版本创建时间2026/06/05 09:23:13 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600126208 

最近更新日期:

Date of Last Refreshed on:

2026-06-05 09:23:04 

注册时间:

Date of Registration:

2026-06-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于行为经济学的胰腺疾病患者健康行为促进的护理研究

Public title:

A nursing study on health behavior promotion in patients with pancreatic diseases based on behavioral economics

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于行为经济学的胰腺疾病患者健康行为促进的护理研究

Scientific title:

A nursing study on health behavior promotion in patients with pancreatic diseases based on behavioral economics

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

任茜 

研究负责人:

任茜 

Applicant:

Ren Qian 

Study leader:

Ren Qian 

申请注册联系人电话:

Applicant telephone:

+86 187 9608 9648

研究负责人电话:

Study leader's
telephone:

+86 511 8891 5150

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

123449576@qq.com

研究负责人电子邮件:

Study leader's E-mail:

123449576@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省镇江市电力路8号

研究负责人通讯地址:

江苏省镇江市电力路8号

Applicant address:

8 Dianli Road, Zhenjiang, Jiangsu

Study leader's address:

8 Dianli Road, Zhenjiang, Jiangsu

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

镇江市第一人民医院

Applicant's institution:

Zhenjiang First People's Hospital

研究负责人所在单位:

镇江市第一人民医院

Affiliation of the Leader:

Zhenjiang First People's Hospital (Affiliated People’s Hospital of Jiangsu University)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

[2026]KY070

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

镇江市第一人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Affiliated People's Hospital of Jiangsu University

伦理委员会批准日期:

Date of approved by ethic committee:

2026-05-21 00:00:00

伦理委员会联系人:

闻向梅

Contact Name of the ethic committee:

Wen XiangMei

伦理委员会联系地址:

江苏省镇江市电力路8号

Contact Address of the ethic committee:

8 Dianli Road, Zhenjiang, Jiangsu

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 511 8891 7729

伦理委员会联系人邮箱:

Contact email of the ethic committee:

wenxiangmei@126.com

研究实施负责(组长)单位:

镇江市第一人民医院

Primary sponsor:

Zhenjiang First People's Hospital (Affiliated People’s Hospital of Jiangsu University)

研究实施负责(组长)单位地址:

江苏省镇江市电力路8号

Primary sponsor's address:

8 Dianli Road, Zhenjiang, Jiangsu

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

Country:

China

Province:

Jiangsu

City:

单位(医院):

镇江市第一人民医院

具体地址:

江苏省镇江市电力路8号

Institution
hospital:

Zhenjiang First People's Hospital (Affiliated People’s Hospital of Jiangsu University)

Address:

8 Dianli Road, Zhenjiang, Jiangsu

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

Self-selected project (self-funded)

研究疾病:

胰腺疾病不良的生活行为;情绪性进食;压力性进食;“知行分离”  

Target disease:

Unhealthy lifestyle behaviors associated with pancreatic diseases; emotional eating; stress eating; knowledge-action gap

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

基于行为经济学与情绪——奖赏驱动进食理论,系统阐明胰腺疾病患者不健康进食行为的形成机制,明确关键健康行为在疾病复发中的作用路径,构建护理主导、可持续的健康行为促进理论框架与干预策略,为降低胰腺疾病复发风险提供科学依据。 1.阐明胰腺疾病患者在肥胖与压力背景下,情绪性进食、奖赏驱动进食与决策失衡共同作用的不健康进食行为形成机制。 2.明确与胰腺疾病复发风险高度相关的关键健康行为指标,区分“可改变行为因素”与“背景易感因素”。 3.构建“肥胖/压力—情绪与奖赏驱动—决策过程—进食行为—复发风险”的整合概念模型。 4.基于行为经济学原理,提出护理主导健康行为促进策略框架,验证干预效果。  

Objectives of Study:

Based on behavioral economics and the emotion-reward driven eating theory, this study aims to systematically elucidate the formation mechanism of unhealthy eating behaviors in patients with pancreatic diseases, clarify the pathways through which key health behaviors influence disease recurrence, construct a nursing-led, sustainable theoretical framework and intervention strategy for health behavior promotion, and provide a scientific basis for reducing the risk of pancreatic disease recurrence.Elucidate the formation mechanism of unhealthy eating behaviors in patients with pancreatic diseases under the context of obesity and chronic stress, wherein emotional eating, reward-driven eating, and decision-making imbalance collectively contribute.Identify key health behavior indicators that are highly associated with the risk of pancreatic disease recurrence, distinguishing between "modifiable behavioral factors" and "background predisposing factors".Construct an integrated conceptual model of "obesity/stress — emotion and reward drive — decision-making process — eating behavior — recurrence risk".Based on the principles of behavioral economics, propose a nursing-led strategic framework for health behavior promotion and evaluate the intervention effects.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.诊断明确的急性胰腺炎、复发性急性胰腺炎(≥2次发作)、慢性胰腺炎(影像学或功能学证据);
2.年龄18-90岁;
3.具备至少一项复发相关可改变行为风险因素:自我报告存在情绪性进食;存在奖赏驱动进食行为;出院后饮食依从性差;
4.处于缓解期或恢复期;
5.具备基本沟通与理解能力;
6.自愿参加并签署书面知情同意书;

Inclusion criteria

1.Patients with a definite diagnosis of acute pancreatitis, recurrent acute pancreatitis (≥2 episodes), or chronic pancreatitis (with imaging or functional evidence).
2.Age 18–90 years;
3.Possess at least one modifiable behavioral risk factor associated with recurrence: self-reported emotional eating; presence of reward-driven eating behavior; poor dietary adherence after discharge.
4.In remission or in the recovery phase;
5.Possess basic communication and comprehension skills.
6.Voluntarily participate and sign a written informed consent form.

排除标准:

1.严重认知障碍或精神疾病:如痴呆、精神分裂症、重度抑郁伴自杀风险,无法配合干预或数据收集;
2.合并其他严重器质性疾病:如晚期恶性肿瘤、严重心力衰竭、终末期肾病等,预期寿命<6个月;
3.妊娠或哺乳期女性(因饮食干预及体重管理可能涉及特殊生理状态);
4.存在明确的胰腺疾病手术治疗或内镜干预后:如胰腺坏死组织清除术后、胰管支架置入后1个月内(急性期影响行为评估);
5.参与其他同类行为干预研究:避免干预混杂 无法完成随访:如计划长期离院、无稳定联系方式等;

Exclusion criteria:

1.Severe cognitive impairment or mental illness, such as dementia, schizophrenia, or major depression with suicide risk, that precludes cooperation with intervention or data collection.
2.Complicated with other severe organic diseases, such as advanced malignant tumors, severe heart failure, end-stage renal disease, etc., with a life expectancy of less than 6 months.
3.Pregnant or breastfeeding women (due to the potential involvement of special physiological states in dietary intervention and weight management).
4.Presence of a history of definite surgical treatment or endoscopic intervention for pancreatic disease, such as after pancreatic necrosectomy or within 1 month after pancreatic stent placement (the acute phase may affect behavioral assessment).
5.Participation in other similar behavioral intervention studies (to avoid intervention contamination). Inability to complete follow-up, e.g., planned long-term discharge from the hospital, lack of stable contact information, etc.

研究实施时间:

Study execute time:

From 2026-05-16 00:00:00 To 2028-05-16 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-05 00:00:00 To 2026-08-22 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

36

Group:

Intervention group

Sample size:

干预措施:

胰腺疾病患者健康行为促进

干预措施代码:

Intervention:

Health behavior promotion in patients with pancreatic diseases

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏省 

市(区县):

 

Country:

China

Province:

Jiangsu

City:

单位(医院):

镇江市第一人民医院 

单位级别:

三级甲等 

Institution
hospital:

Zhenjiang First People's Hospital (Affiliated People’s Hospital of Jiangsu University)

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

健康饮食行为遵从率

指标类型:

主要指标

Outcome:

Adherence rate to healthy eating behaviors

Type:

Primary indicator

测量时间点:

出院前、干预4周、3个月随访

测量方法:

胰腺疾病专用饮食行为自评表

Measure time point of outcome:

Before discharge, at 4 weeks of intervention, and at 3-month follow-up

Measure method:

Pancreatic Disease-Specific Dietary Behavior Self-Rating Scale

指标中文名:

简化行为评估

指标类型:

次要指标

Outcome:

Simplified Behavior Assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

情绪性进食

指标类型:

次要指标

Outcome:

Emotional eating

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 90 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

数字随机法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

开放标签,对评估者隐藏分组

Blinding:

Open-label study with blinded-evaluators

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

在主要研究成果发表后(预计2028年6月),将在 开放科学框架(Open Science Framework, OSF) 平台上公开去标识化后的原始数据。公开内容包括:定量数据(量表评分、人口学与临床指标)的CSV文件;数据字典(变量说明);研究方案与统计分析代码(R或SPSS语法) OSF网址:https://osf.io/

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

After publication of primary results (expected June 2028), de-identified individual participant data (IPD) will be shared on the Open Science Framework (OSF) repository. Shared content includes: quantitative data (CSV format), data dictionary, study protocol, and statistical analysis code. URL: https://osf.io/ .

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表(CRF):采用纸质版CRF记录参与者的人口学信息、疾病临床资料、行为量表评分(情绪性进食量表、饮食依从性评分等)以及随访数据。每份CRF由双人核对,签字后存放于医院研究中心的专用上锁文件柜,保存至研究结束后10年。 电子采集和管理系统(EDC):使用 REDCap(Research Electronic Data Capture) 系统搭建电子数据库。REDCap系统部署在医院内网服务器,具备用户角色权限控制、数据逻辑核查、自动质控和审计追踪功能。双人独立录入,系统自动比对不一致项。数据导出需经项目负责人和伦理委员会批准,导出文件加密并去标识化。备份策略:每日增量备份,每周全量备份至医院信息科安全存储区。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form (CRF): CRF collects demographics, clinical data, behavioral scale scores (emotional eating scale, dietary adherence scores), and follow-up data. Each CRF is double-checked and signed, stored in a locked cabinet at the hospital research center for 10 years after study completion.Electronic Data Capture (EDC): Using REDCap (hosted on hospital intranet) with role-based access, data validation, auto-checks, and audit trail. Double data entry with discrepancy resolution. Data export requires PI and IRB approval, encrypted and de-identified. Backup: daily incremental, weekly full backup to hospital IT secure storage.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-06-05 09:23:04